Literature DB >> 14764757

Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods.

Karen K Miller1, William Rosner, Hang Lee, Joan Hier, Gemma Sesmilo, David Schoenfeld, Gregory Neubauer, Anne Klibanski.   

Abstract

Androgen deficiency in women is increasingly recognized as a new clinical syndrome and has raised our awareness of the importance of accurate and well-validated measurements of serum free testosterone (T) concentrations in women. Therefore, we compared serum free T levels measured by equilibrium dialysis to those measured by a direct RIA (analog method) and to those calculated from the law of mass action (requires the measurement of total T and SHBG). We also calculated the free androgen index, 100 x T/SHBG, as a simple index known to correlate with free T. Subjects were 147 women with variable androgen and estrogen statuses. All were studied three times in 1 month and included women 1) with regular menses (estrogen positive, T positive), 2) more than 50 yr old and not receiving estrogen (estrogen negative, T positive), 3) receiving estrogen (estrogen positive, T negative), and 4) with severe androgen deficiency secondary to hypopituitarism (estrogen negative, T negative). Calculated values for free T using the laws of mass action correlated well with those obtained from equilibrium dialysis (r = 0.99; P < 0.0001). However, the agreement depended strongly on the specific assays used for total T and SHBG. In contrast, the direct RIA method had unacceptably high systematic bias and random variability and did not correlate as well with equilibrium dialysis values (r = 0.81; P < 0.0001). In addition, the lower limit of detection was higher for the direct RIA than for equilibrium dialysis or calculated free T. Free androgen index correlates well with free T by equilibrium dialysis (r = 0.93; P < 0.0001), but is a unitless number without reference to the physical reality of free T. We conclude that the mass action equation and equilibrium dialysis are the preferred methods for use in diagnosing androgen deficiency in women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764757     DOI: 10.1210/jc.2003-030680

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  60 in total

1.  The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2012-01-13       Impact factor: 2.226

2.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

3.  Determinants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesity.

Authors:  D J Brick; A V Gerweck; E Meenaghan; E A Lawson; M Misra; P Fazeli; W Johnson; A Klibanski; K K Miller
Journal:  Eur J Endocrinol       Date:  2010-05-25       Impact factor: 6.664

4.  Are routine testosterone assays good enough?

Authors:  Sydney S Sacks
Journal:  Clin Biochem Rev       Date:  2005-02

5.  Standardised, metabolite-specific assays with validated decision limits: utopian ideal or achievable goal?

Authors:  Paul Glendenning
Journal:  Clin Biochem Rev       Date:  2005-02

6.  A randomized trial of the effect of estrogen and testosterone on economic behavior.

Authors:  Niklas Zethraeus; Ljiljana Kocoska-Maras; Tore Ellingsen; Bo von Schoultz; Angelica Lindén Hirschberg; Magnus Johannesson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

7.  Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.

Authors:  Tomoko Asagami; Tyson H Holmes; Gerald Reaven
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

8.  Birthweight, mediating biomarkers and the development of type 2 diabetes later in life: a prospective study of multi-ethnic women.

Authors:  Yan Song; Yen-Tsung Huang; Yiqing Song; Andrea L Hevener; Kelli K Ryckman; Lihong Qi; Erin S LeBlanc; Rasa Kazlauskaite; Kathleen M Brennan; Simin Liu
Journal:  Diabetologia       Date:  2015-01-08       Impact factor: 10.122

9.  Sex hormone-binding globulin and risk of clinical diabetes in American black, Hispanic, and Asian/Pacific Islander postmenopausal women.

Authors:  Brian H Chen; Kathleen Brennan; Atsushi Goto; Yiqing Song; Najib Aziz; Nai-chieh Y You; Melissa F Wellons; JoAnn E Manson; Donna L White; Anthony W Butch; Simin Liu
Journal:  Clin Chem       Date:  2012-08-20       Impact factor: 8.327

10.  Daily bisphenol A excretion and associations with sex hormone concentrations: results from the InCHIANTI adult population study.

Authors:  Tamara Galloway; Riccardo Cipelli; Jack Guralnik; Luigi Ferrucci; Stefania Bandinelli; Anna Maria Corsi; Cathryn Money; Paul McCormack; David Melzer
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.